Annual Long Term Debt
$22.93 B
+$2.90 B+14.48%
December 31, 2024
Summary
- As of February 7, 2025, NVS annual long term debt is $22.93 billion, with the most recent change of +$2.90 billion (+14.48%) on December 31, 2024.
- During the last 3 years, NVS annual long term debt has fallen by -$1.59 billion (-6.48%).
- NVS annual long term debt is now -18.03% below its all-time high of $27.98 billion, reached on December 31, 2020.
Performance
NVS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$22.93 B
-$2.41 B-9.52%
December 31, 2024
Summary
- As of February 7, 2025, NVS quarterly long term debt is $22.93 billion, with the most recent change of -$2.41 billion (-9.52%) on December 31, 2024.
- Over the past year, NVS quarterly long term debt has increased by +$2.90 billion (+14.48%).
- NVS quarterly long term debt is now -18.62% below its all-time high of $28.18 billion, reached on September 30, 2020.
Performance
NVS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
NVS Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.5% | +14.5% |
| 3 y3 years | -6.5% | +17.5% |
| 5 y5 years | +4.0% | +17.5% |
NVS Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +14.5% | -9.5% | +22.5% |
| 5 y | 5-year | -18.0% | +14.5% | -18.6% | +22.5% |
| alltime | all time | -18.0% | +3396.0% | -18.6% | +3528.8% |
Novartis AG Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $22.93 B(+14.5%) | $22.93 B(-9.5%) |
| Sep 2024 | - | $25.35 B(+19.4%) |
| Jun 2024 | - | $21.22 B(+13.4%) |
| Mar 2024 | - | $18.72 B(-6.6%) |
| Dec 2023 | $20.03 B(-8.0%) | $20.03 B(+2.6%) |
| Sep 2023 | - | $19.52 B(-1.4%) |
| Jun 2023 | - | $19.80 B(-9.9%) |
| Mar 2023 | - | $21.98 B(+0.9%) |
| Dec 2022 | $21.78 B(-11.2%) | $21.78 B(+2.6%) |
| Sep 2022 | - | $21.23 B(-10.7%) |
| Jun 2022 | - | $23.78 B(-2.4%) |
| Mar 2022 | - | $24.37 B(-0.6%) |
| Dec 2021 | $24.52 B(-12.3%) | $24.52 B(-0.8%) |
| Sep 2021 | - | $24.71 B(-6.7%) |
| Jun 2021 | - | $26.49 B(-3.3%) |
| Mar 2021 | - | $27.40 B(-2.1%) |
| Dec 2020 | $27.98 B(+26.8%) | $27.98 B(-0.7%) |
| Sep 2020 | - | $28.18 B(+9.9%) |
| Jun 2020 | - | $25.65 B(+0.6%) |
| Mar 2020 | - | $25.49 B(+15.6%) |
| Dec 2019 | $22.06 B(-1.8%) | $22.06 B(+1.0%) |
| Sep 2019 | - | $21.83 B(-1.3%) |
| Jun 2019 | - | $22.12 B(-3.4%) |
| Mar 2019 | - | $22.89 B(+1.9%) |
| Dec 2018 | $22.47 B(-3.2%) | $22.47 B(-0.6%) |
| Sep 2018 | - | $22.61 B(-0.7%) |
| Jun 2018 | - | $22.76 B(-1.9%) |
| Mar 2018 | - | $23.20 B(-0.1%) |
| Dec 2017 | $23.22 B(+29.8%) | $23.22 B(+0.3%) |
| Sep 2017 | - | $23.16 B(+0.7%) |
| Jun 2017 | - | $23.00 B(+0.3%) |
| Mar 2017 | - | $22.93 B(+28.1%) |
| Dec 2016 | $17.90 B(+9.6%) | $17.90 B(-2.0%) |
| Sep 2016 | - | $18.26 B(+12.2%) |
| Jun 2016 | - | $16.28 B(-1.1%) |
| Mar 2016 | - | $16.46 B(+0.8%) |
| Dec 2015 | $16.33 B(+18.3%) | $16.33 B(+21.7%) |
| Sep 2015 | - | $13.41 B(+0.8%) |
| Jun 2015 | - | $13.30 B(-10.3%) |
| Mar 2015 | - | $14.83 B(+7.5%) |
| Dec 2014 | $13.80 B(+22.7%) | $13.80 B(+8.9%) |
| Sep 2014 | - | $12.67 B(-1.6%) |
| Jun 2014 | - | $12.87 B(-15.3%) |
| Mar 2014 | - | $15.20 B(+35.2%) |
| Dec 2013 | $11.24 B(-18.4%) | $11.24 B(+1.1%) |
| Sep 2013 | - | $11.12 B(-4.3%) |
| Jun 2013 | - | $11.62 B(+0.0%) |
| Mar 2013 | - | $11.61 B(-15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $13.78 B(-0.5%) | $13.78 B(-12.9%) |
| Sep 2012 | - | $15.82 B(+15.0%) |
| Jun 2012 | - | $13.75 B(-1.0%) |
| Mar 2012 | - | $13.90 B(+0.3%) |
| Dec 2011 | $13.86 B(-3.5%) | $13.86 B(+0.9%) |
| Sep 2011 | - | $13.74 B(-1.3%) |
| Jun 2011 | - | $13.92 B(-4.2%) |
| Mar 2011 | - | $14.53 B(+1.2%) |
| Dec 2010 | $14.36 B(+65.5%) | $14.36 B(+0.2%) |
| Sep 2010 | - | $14.33 B(+8.3%) |
| Jun 2010 | - | $13.23 B(-1.6%) |
| Mar 2010 | - | $13.45 B(+55.0%) |
| Dec 2009 | $8.68 B(+298.3%) | $8.68 B(-0.4%) |
| Sep 2009 | - | $8.71 B(-5.3%) |
| Jun 2009 | - | $9.20 B(+31.8%) |
| Mar 2009 | - | $6.98 B(+220.4%) |
| Dec 2008 | $2.18 B(+221.7%) | $2.18 B(+5.6%) |
| Sep 2008 | - | $2.06 B(-5.0%) |
| Jun 2008 | - | $2.17 B(+190.4%) |
| Mar 2008 | - | $748.00 M(+10.5%) |
| Dec 2007 | $677.00 M(+3.2%) | $677.00 M(+1.5%) |
| Sep 2007 | - | $667.00 M(+5.5%) |
| Jun 2007 | - | $632.00 M(-4.4%) |
| Mar 2007 | - | $661.00 M(+0.8%) |
| Dec 2006 | $656.00 M(-50.3%) | $656.00 M(-66.6%) |
| Sep 2006 | - | $1.96 B(+21.4%) |
| Jun 2006 | - | $1.62 B(+20.3%) |
| Mar 2006 | - | $1.34 B(+1.9%) |
| Dec 2005 | $1.32 B(-51.8%) | $1.32 B(-45.8%) |
| Sep 2005 | - | $2.44 B(-2.3%) |
| Jun 2005 | - | $2.49 B(-3.8%) |
| Mar 2005 | - | $2.59 B(-5.3%) |
| Dec 2004 | $2.74 B(-14.3%) | $2.74 B(-6.1%) |
| Sep 2004 | - | $2.92 B(-6.1%) |
| Jun 2004 | - | $3.10 B(-1.3%) |
| Mar 2004 | - | $3.15 B(-1.4%) |
| Dec 2003 | $3.19 B(+16.9%) | $3.19 B(+4.9%) |
| Sep 2003 | - | $3.04 B(+0.7%) |
| Jun 2003 | - | $3.02 B(+4.3%) |
| Mar 2003 | - | $2.90 B(+6.2%) |
| Dec 2002 | $2.73 B(+81.4%) | $2.73 B(+72.2%) |
| Sep 2002 | - | $1.58 B(-0.6%) |
| Jun 2002 | - | $1.59 B(+6.1%) |
| Dec 2001 | $1.50 B(+6.3%) | $1.50 B(+9.1%) |
| Jun 2001 | - | $1.38 B(-2.6%) |
| Dec 2000 | $1.42 B(-7.8%) | $1.42 B(-0.3%) |
| Jun 2000 | - | $1.42 B |
| Dec 1999 | $1.53 B(-25.6%) | - |
| Dec 1998 | $2.06 B | - |
FAQ
- What is Novartis AG annual long term debt?
- What is the all time high annual long term debt for Novartis AG?
- What is Novartis AG annual long term debt year-on-year change?
- What is Novartis AG quarterly long term debt?
- What is the all time high quarterly long term debt for Novartis AG?
- What is Novartis AG quarterly long term debt year-on-year change?
What is Novartis AG annual long term debt?
The current annual long term debt of NVS is $22.93 B
What is the all time high annual long term debt for Novartis AG?
Novartis AG all-time high annual long term debt is $27.98 B
What is Novartis AG annual long term debt year-on-year change?
Over the past year, NVS annual long term debt has changed by +$2.90 B (+14.48%)
What is Novartis AG quarterly long term debt?
The current quarterly long term debt of NVS is $22.93 B
What is the all time high quarterly long term debt for Novartis AG?
Novartis AG all-time high quarterly long term debt is $28.18 B
What is Novartis AG quarterly long term debt year-on-year change?
Over the past year, NVS quarterly long term debt has changed by +$2.90 B (+14.48%)